La Jolla prices $100.3M follow-on

La Jolla Pharmaceutical Co. (NASDAQ:LJPC) raised $100.3 million through the sale of 3.4 million shares at $29.50 in a follow-on underwritten by Cowen. The price is a 1% discount to La Jolla's close of $29.84 on Wednesday, when the company proposed the offering after market close.

The biotech's Giapreza angiotensin II is approved to increase blood pressure in adults with septic or other distributive shock. The drug is a renin-angiotensin system peptide agonist...